There are 2867 resources available
LBA69 - Belzutifan, a HIF-2α Inhibitor, for von Hippel-Lindau (VHL) disease-associated neoplasms: 36 months of follow-up of the phase II LITESPARK-004 study
Presenter: Ramaprasad Srinivasan
Session: Mini Oral session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Beyond first-line: Best practices and practical nuances
Presenter: Timothy Price
Session: Personalizing treatment for mCRC in 2022
Resources:
Slides
Webcast
Diffuse large B-cell lymphoma
Presenter: Martin Hutchings
Session: Early relapses in lymphoma: How to treat?
Resources:
Slides
Webcast
Biological basis of exercise and physical activity on quality of life in cancer survivors
Presenter: Justin Jeon
Session: Leveraging biology and technology to improve symptoms and quality of life of cancer survivors
Resources:
Slides
Webcast
PSMA for diagnosis and staging
Presenter: Daniela Oprea-Lager
Session: Prostate-specific membrane antigen (PSMA) biology, diagnostics and treatment
Resources:
Slides
Webcast
Invited Discussant 1646MO and 1647MO
Presenter: Maria Cabanillas
Session: Mini Oral session: NETs and endocrine tumours
Resources:
Slides
Webcast
Identifying targetable risk and prevention biomarkers: Example of the lung pre-cancer molecular landscape
Presenter: Samuel Janes
Session: How advances in biology and technology are transforming the field of cancer prevention & early detection
Resources:
Slides
Webcast
ABC4Nurses: Education programme based on Delphi study outcomes
Presenter: Amanda Drury
Session: Professional and educational issues in cancer nursing
Resources:
Slides
Webcast
Innovation drug discovery
Presenter: Shiva Malek
Session: ESMO meets pharma: Next frontiers in drug discoveries
Resources:
Slides
Webcast
How to move between PhD and medical oncology
Presenter: Anna Sophie Berghoff
Session: Young Oncologist Forum: Going on a Research Journey: From grant writing, over PhD to team management
Resources:
Slides
Webcast